BERTOMORO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.284
AS - Asia 253
EU - Europa 248
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 2.790
Nazione #
US - Stati Uniti d'America 2.283
CN - Cina 160
VN - Vietnam 85
FI - Finlandia 55
IT - Italia 53
SE - Svezia 53
DE - Germania 31
GB - Regno Unito 22
UA - Ucraina 8
NL - Olanda 7
TR - Turchia 5
BE - Belgio 4
EU - Europa 3
FR - Francia 3
IE - Irlanda 3
DK - Danimarca 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
CA - Canada 1
CH - Svizzera 1
HU - Ungheria 1
JP - Giappone 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.790
Città #
Fairfield 463
Chandler 237
Woodbridge 204
Ashburn 192
Cambridge 157
Seattle 155
Wilmington 153
Houston 146
Ann Arbor 85
Dong Ket 85
Jacksonville 67
Beijing 60
Princeton 51
San Diego 37
Medford 28
Nanjing 28
Padova 22
Helsinki 20
Boardman 16
Roxbury 15
Des Moines 12
Changsha 11
Norwalk 11
Hebei 8
Shenyang 7
Nanchang 6
New York 6
Washington 6
Hefei 5
Istanbul 5
Jiaxing 4
London 4
Nutley 4
Borås 3
Chicago 3
Dublin 3
Fuzhou 3
Indiana 3
Redwood City 3
Brussels 2
Dallas 2
Florence 2
Hangzhou 2
Kilburn 2
Kunming 2
Las Vegas 2
Milan 2
Phoenix 2
Rome 2
Simi Valley 2
Stockholm 2
Tomblaine 2
Waanrode 2
Wandsworth 2
Atlanta 1
Auckland 1
Bratislava 1
Brendola 1
Brisbane 1
Budapest 1
Chengdu 1
Copenhagen 1
Denver 1
Dubai 1
Fontenay-sous-bois 1
Haikou 1
Jinan 1
Jinhua 1
Livorno 1
Luxembourg 1
Lyngby 1
Malo 1
Oslo 1
San Francisco 1
Southwark 1
Tappahannock 1
Tianjin 1
Warsaw 1
Wenzhou 1
Wuhan 1
Zurich 1
Totale 2.385
Nome #
Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease. 142
Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue 121
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 105
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases 97
A 29-year-old woman with persistent thrombocytopenia 95
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 93
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 92
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 90
A novel von Willebrand factor mutation (11372S) associated with type 2B-like von Willebrand disease: An elusive phenotype and a difficult diagnosis 85
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 84
Spontaneous recurrent intracranial haemorrhage in a woman with type 2B von Willebrand disease: A clinical case and a brief literature review 84
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 83
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 79
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 78
Type I Padua: a new variant of von Willebrand's disease. 74
Which assay is the most suitable to investigate von Willebrand factor functional activity? 74
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunction. 73
Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 73
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. 72
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. 71
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. 70
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. 69
On the release of von Willebrand factor from endothelial cells after venous occlusion. 67
Demonstration that venous occlusion fails to release von Willebrand factor multimers. 66
Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease. 66
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors. 66
Combined exon skipping and cryptic splice activation as a new molecular mechanism for recessive type 1 von Willebrand disease. 65
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. 65
Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. 64
Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome. 64
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 58
On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease. 52
The Bleeding Assessment Tool and laboratory data in the characterisation of a female with inherited haemophilia A 49
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. 47
An apparent silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease. 45
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. 44
Discrepant increase in factor VIII: C and von Willebrand factor after DDAVP infusion in a patient with variant von Willebrand's disease. 43
Identifying carriers of type 2N von Willebrand disease: procedures and significance. 38
Totale 2.803
Categoria #
all - tutte 8.968
article - articoli 8.968
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019267 0 0 0 0 0 0 0 0 0 52 121 94
2019/2020659 101 20 16 38 74 43 62 90 76 49 60 30
2020/2021466 25 27 12 40 11 33 37 29 52 56 39 105
2021/2022563 23 59 84 34 41 44 33 55 19 12 77 82
2022/2023449 80 60 10 46 78 52 2 33 48 1 36 3
2023/2024176 4 39 27 21 25 31 19 9 1 0 0 0
Totale 2.803